Cambrex Corporation invests around $50 million for expansion of lowa API plant
Introduction:
Cambrex Corporation announced plans that it has initiated the second significant expansion of its Charles City, Iowa facility with an investment of approx $50 million.
Features:
This investment includes a state of the art cGMP production facility and related supporting infrastructure. This project is expected to be completed in early 2016.
The new manufacturing facility will initially add a total of 70 cubic meters of glass lined and hastelloy reactors ranging in size from 7m3 to 16m3 along with 6m2 hastelloy filter dryers to provide a flexible, multi-purpose configuration. The facility will be designed to the highest regulatory and safety standards, capable of handling potent APIs at an OEL down to 1µg/m3 and will significantly increase the Company’s cGMP manufacturing capabilities.
The facility is also expandable with the ability to add additional capacity on a short timeline. The capacity is being added along with 45,000 square feet of new fully cGMP, temperature and humidity controlled warehouse space.
Specifications:
| Company Name | Cambrex Corporation |
| Location | Iowa |
| Type | Expansion |
| End Year | 2016 |
| Estimated Cost | Approx $50 million |
